Wednesday Brain Dump: February 18, 2009
Good thing I waited until evening, because this week’s post is mammoth. Funny, right? So funny, this post may go viral… The Nipah virus may be stopped more easily than expected and a vaccine for...
View ArticleWednesday Brain Dump: February 25, 2009
The question this week: a shot in the arm or a kick in the teeth? A shot in the arm for: Fewer shots in the arm! (har) British Columbia is the first jurisdiction in North America to offer a children’s...
View ArticleWednesday Brain Dump: March 4, 2009
Monkey Business: glycerol monolaurate (GML), a well-known microbicide, may protect macaques against SIV; but future experiments may need to use a modified HIV strain instead; meanwhile, who will...
View ArticleWednesday Brain Dump: March 11, 2009
Regulatory Brain Dump… Regulating Nanotech: The FDA is collaborating with the Houston-based Alliance for NanoHealth (ANH) and its eight member institutions to expand knowledge of how nanoparticles...
View ArticleWednesday Brain Dump: Food Edition
Here’s a food edition of the Wednesday Brain Dump, but it’s all about limits: Limiting Salt Intake: A new epidemiological model predicts major benefits from minor reductions in salt intake. Limiting...
View ArticleWednesday Brain Dump: Around the World Edition
View Larger Map Click on the map points for each story, or just read on Ottawa: The Ottawa Centre for Research and Innovation has announced Claude Haw will be its new president and CEO. OCRI assists...
View ArticleWednesday Brain Dump: Deal-O-Rama Edition
There’s still plenty of deal activity in the pharma and biotech sector this week, even outside Canada, so here’s a roundup of what’s done, what’s pending and what’s in the rumor mill: Done: Genzyme...
View ArticleWednesday Brain Dump: Things that Might Surprise You Edition
Things that surprised me this week: AstraZeneca’s CEO David Brennan, elected PhRMA’s new chairman, spoke in favour of comparative effectiveness research, calling it “a market requirement.” PolyCap, a...
View ArticleWednesday Brain Dump: Two of Everything! Edition
Two Camels! Dolly the cloned sheep, meet Injaz the cloned camel. Two R&D Heads! The combined Pfizer-Wyeth will have Mikael Dolsten heading up the newly created BioTherapeutics Research Group and...
View ArticleWednesday Brain Dump: Plant Matter Edition
Some stories from the world of plant biotech: Ben-Gurion University is collaborating with Bayer BioScience NV to fund work at Simon Barak’s lab investigating genes to help plants cope with heat,...
View Article
More Pages to Explore .....